Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.
about
Characterization of Fibrinogen Binding by Glycoproteins Srr1 and Srr2 of Streptococcus agalactiaeGenetic diversity and antimicrobial resistance in Streptococcus agalactiae strains recovered from female carriers in the Bucharest area.Epidemic Klebsiella pneumoniae ST258 is a hybrid strain.Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, CanadaSequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes.Serotypes of group B streptococci in western Sweden and comparison with serotypes in two previous studies starting from 1988.A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice.Comparative Genome Analyses of Streptococcus suis Isolates from Endocarditis Demonstrate Persistence of Dual Phenotypic Clones.Clonal Complex 17 Group B Streptococcus strains causing invasive disease in neonates and adults originate from the same genetic poolEpidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya.Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages.Molecular Characterization of Streptococcus agalactiae Causing Community- and Hospital-Acquired Infections in Shanghai, China.Genomic Recombination Leading to Decreased Virulence of Group B Streptococcus in a Mouse Model of Adult Invasive Disease.Molecular Characteristics of Group B Streptococci Isolated from Adults with Invasive Infections in Japan.Capsular Switching and Other Large-Scale Recombination Events in Invasive Sequence Type 1 Group B Streptococcus.Immune Responses to Invasive Group B Streptococcal Disease in Adults.Real-time PCR-based serotyping of Streptococcus agalactiaeAcidic pH strongly enhances in vitro biofilm formation by a subset of hypervirulent ST-17 Streptococcus agalactiae strains.Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada.Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.Parallel Evolution of Group B Streptococcus Hypervirulent Clonal Complex 17 Unveils New Pathoadaptive Mutations.Investigation of serotype distribution and resistance genes profile in group B Streptococcus isolated from pregnant women: a Chinese multicenter cohort study.Molecular epidemiology of Streptococcus agalactiae recovered from significant bacteriuria.The emergence of bacterial "hopeful monsters"Codevelopment of Microbiota and Innate Immunity and the Risk for Group B Streptococcal Disease.Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy.Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.Status of group B streptococcal vaccine development.Emergence of the L phenotype in Group B Streptococci in the South of Ireland.Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.Perinatal Streptococcus agalactiae Epidemiology and Surveillance TargetsPhenotypic and molecular analysis of nontypeable Group B streptococci: identification of cps2a and hybrid cps2a/cps5 Group B streptococcal capsule gene clusters
P2860
Q27680474-E48DFE43-68A5-473E-B628-392660C49C5DQ33587116-1BEE2A08-8378-43C2-8488-01DF01E50566Q33815077-874A49B0-370B-432B-B63D-5D03D6710155Q35229670-3EC689F2-84B4-4BC2-BCCF-187483876A6FQ35644798-79F3CB77-61B1-4646-B8B0-EB8F7AE378A1Q35836791-0B6540C4-EA4A-4773-80CD-8EDCBE8C3EE7Q35870249-7EC03526-4177-44F0-9BB7-A6958C6555A8Q36081531-21D9DF1F-8E65-47DB-B8D1-243B83CCACA9Q36542167-EF09CD3D-4D67-485A-ACC5-8EF651879EB6Q37040500-0458B1AA-F7CC-4196-8D23-76E03F0A8935Q37074413-F3FC2533-BAB4-4E3A-85DF-9D2C3691492DQ37093287-533B542C-4CD4-4C3A-8A96-585C4CC6642DQ37214961-5858A530-57D2-4468-AFD9-DDE95649DF74Q37290710-9C6EFAC3-4F1C-4C51-AA79-AEF1B95E0709Q37363399-5F0AFE8B-A084-4AB5-9C61-9889FA8308AEQ37381946-CA707E12-5C86-4EDC-9378-3F933DB4AF2AQ37382005-3032A9FF-8E94-4DA8-91AD-A28D5933F2F2Q37464437-3D3D53A8-EB4F-43BA-999C-25FC55ADBDB2Q37712890-C9DE4A58-40A7-47CC-A78D-08B125E420AFQ37713818-B03D3CE1-5D53-41DB-B2AD-229D38EE1839Q39386700-204CE8FD-7DAA-473F-97AB-2968E13D251BQ40047331-8AFE7911-CABB-4124-BE14-F9E10D1FCD46Q40601705-15A8610E-6680-4E1D-9C71-581BBFA8CD88Q41297811-396E46BD-C287-47BF-AA78-CD0361B2ED9EQ41865750-5C0C57EB-5FE3-463F-B1E3-8A42F0CE1910Q46247272-C6283358-A596-4880-B3B9-4131E83520A6Q46470356-AA929B1B-6A2D-49D2-8CDF-301FB5A76743Q48024306-03C5E489-8F1F-4E95-B982-7EBBD29E9A70Q48041915-39AD8330-10AF-4040-A770-601E23E93032Q48364677-19FA4D3C-0913-4B74-BA97-73E74DE7A017Q52624533-3C028E6C-DE2B-4759-B141-7EA53E7C34DDQ57169196-A05648A3-6AC6-4DAF-9F38-27FF5CF560C3Q58796412-5D117091-C544-49A1-94D7-032ED61925E2
P2860
Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Capsular switching in group B ...... accharide vaccine development.
@en
Capsular switching in group B ...... accharide vaccine development.
@nl
type
label
Capsular switching in group B ...... accharide vaccine development.
@en
Capsular switching in group B ...... accharide vaccine development.
@nl
prefLabel
Capsular switching in group B ...... accharide vaccine development.
@en
Capsular switching in group B ...... accharide vaccine development.
@nl
P2093
P2860
P50
P356
P1476
Capsular switching in group B ...... saccharide vaccine development
@en
P2093
Magalie Longo
Nicolas Dmytruk
Philippe Glaser
Samuel Bellais
P2860
P304
P356
10.1093/INFDIS/JIS605
P407
P577
2012-09-21T00:00:00Z